Article
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins.
Medicine - 1 Sept 2015
Bellanti Francesco, Lauletta Gianfranco, Villani Rosanna, Lipsi Maria Rosaria, Natalicchio Maria Iole, Sansonno Domenico, Vendemiale Gianluigi, Serviddio Gaetano
Abstract excerpt
Chronic hepatitis C is commonly associated with extrahepatic manifestations. Cryoglobulins are observed in 40% to 60% of such patients and their presence seems to modify response to therapy. The new antivirals are greatly improving the sustained virological response (SVR); however, their high cost limits the use, leaving pegylated interferon plus ribavirin (PR) still the standard-of-care therapy worldwide. Since...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
